Hypersensitivity reaction to epirubicin

Med Oncol Tumor Pharmacother. 1989;6(4):297-8. doi: 10.1007/BF02985165.

Abstract

A patient with metastatic breast cancer treated with epirubicin (Pharmorubicin) developed a severe urticarial reaction which progressed to ulceration following possible sensitisation to the drug by preceding extravasation.

Publication types

  • Case Reports

MeSH terms

  • Bone Neoplasms / secondary
  • Breast Neoplasms / complications
  • Drug Hypersensitivity*
  • Epirubicin / adverse effects
  • Epirubicin / therapeutic use*
  • Extravasation of Diagnostic and Therapeutic Materials
  • Female
  • Humans
  • Middle Aged

Substances

  • Epirubicin